
A small-molecule inhibitor of TopBP1 exerts anti-MYC activity and synergy with PARP inhibitors
Significance Amplification of MYC and mutation of p53 are frequently found in human cancers, yet directly targeting it has proven difficult. Thus, exploring alternative methods to hinder